CRO
Our CRO business has the potential to yield valuable licensing opportunities spanning multiple therapeutic areas.
ExpreS2ion has successfully developed and produced
over 500 different hard-to-express proteins
with a success rate above 90 percent.
Our CRO services include:
- Fee-for-service contract research and products related to recombinant protein expression.
- Outlicensing the ExpreS2 platform to research institutes and pharmaceutical companies engaged in biopharmaceutical drug and vaccine development, either independently or in partnership with ExpreS2ion.
- Selling ExpreS2 test kits and reagents for research purposes or diagnostic applications.
If you want to know more, please contact: info@expres2ionbio.com or +45 2222 1019